Esophageal Varices Clinical Trial
Official title:
Optimal Time for Follow up After Variceal Band Ligation in Cirrhotic Patients: a Randomized Trial
Optimal time for follow up after variceal band ligation in cirrhotic patients remains to be determined
Status | Recruiting |
Enrollment | 400 |
Est. completion date | December 31, 2021 |
Est. primary completion date | December 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - cirrhotic portal hypertension with medium or large sized or risky varices or variceal bleeding Exclusion Criteria: - non-cirrhotic portal hypertension |
Country | Name | City | State |
---|---|---|---|
Egypt | Sherief Abd-Elsalam | Tanta |
Lead Sponsor | Collaborator |
---|---|
Tanta University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of patients with eradicated varices | The total number of patients with eradicated varices | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06017102 -
Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices
|
N/A | |
Recruiting |
NCT03624517 -
Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
|
Phase 4 | |
Recruiting |
NCT03989973 -
Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
|
||
Completed |
NCT05485714 -
Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
|
||
Completed |
NCT01851252 -
MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy
|
Phase 1 | |
Completed |
NCT01360515 -
A Study of Disposable Transnasal Esophagoscope
|
N/A | |
Recruiting |
NCT04499898 -
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
|
Phase 2/Phase 3 | |
Completed |
NCT00331188 -
Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding
|
Phase 3 | |
Enrolling by invitation |
NCT02767206 -
Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.
|
N/A | |
Enrolling by invitation |
NCT05781828 -
Noninvasive Methods For Prediction of Esophageal Varices in Children
|
||
Not yet recruiting |
NCT05199038 -
Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
|
Phase 4 | |
Recruiting |
NCT02740166 -
Preventing Recurrent Bleeding After Eradication of Esophageal Varices
|
Phase 4 | |
Completed |
NCT01893541 -
PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?
|
Phase 4 | |
Terminated |
NCT00485290 -
Effect of Meal on Portal and Esophagus Variceal Pressure
|
N/A | |
Completed |
NCT01079416 -
Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices
|
N/A | |
Completed |
NCT01188733 -
Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04254822 -
HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients
|
N/A | |
Recruiting |
NCT03212872 -
Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding
|
N/A | |
Completed |
NCT03748563 -
Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis
|
N/A | |
Completed |
NCT01059396 -
Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
|
Phase 4 |